dc.contributorUniversidade Estadual Paulista (UNESP)
dc.contributorInnovatecs Biotechnological Research and Development
dc.contributorUniversity of New South Wales
dc.date.accessioned2022-05-01T09:47:24Z
dc.date.accessioned2022-12-20T03:43:52Z
dc.date.available2022-05-01T09:47:24Z
dc.date.available2022-12-20T03:43:52Z
dc.date.created2022-05-01T09:47:24Z
dc.date.issued2022-02-01
dc.identifierMaterials Letters, v. 308.
dc.identifier1873-4979
dc.identifier0167-577X
dc.identifierhttp://hdl.handle.net/11449/233719
dc.identifier10.1016/j.matlet.2021.131109
dc.identifier2-s2.0-85117583640
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5413818
dc.description.abstractWe evaluated the feasibility of Nanoskin®, a bacterial cellulose (BC) nanofiber membrane, as a potential scaffold for cell transference therapy. Nanoskin® does not induce lymphocyte proliferation, but it does not kill lymphocytes. Human mesenchymal stem cells (MSCs) and lymphocytes produced significantly elevated amounts of interleukin (IL)-10 (p = 0.0005; p = 0.02) when in contact with Nanoskin®. In conclusion, the Nanoskin® can be a promising biomaterial for use as a cell carrier-scaffold in cell transference therapies.
dc.languageeng
dc.relationMaterials Letters
dc.sourceScopus
dc.subjectBacterial cellulose
dc.subjectCell transference
dc.subjectNanoskin®
dc.subjectRegenerative medicine
dc.subjectScaffold
dc.titlePhysical, functional and biochemical features of Nanoskin® bacterial cellulose scaffold as a potential carrier for cell transference
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución